Literature DB >> 25598359

Impact of a chronic total occlusion in an infarct-related artery on the long-term outcome of ventricular tachycardia ablation.

Andrea Di Marco1,2, Gabriele Paglino1, Teresa Oloriz1, Giuseppe Maccabelli1, Francesca Baratto1, Pasquale Vergara1, Caterina Bisceglia1, Ignasi Anguera2, Simone Sala1, Nicoleta Sora1, Paolo Dallaglio2, Alessandra Marzi1, Nicola Trevisi1, Patrizio Mazzone1, Paolo Della Bella1.   

Abstract

INTRODUCTION: In patients with a prior myocardial infarction (MI), angiographic predictors of ventricular tachycardia (VT) recurrence after ablation are lacking. Recently, a proarrhythmic effect of a chronic total occlusion (CTO) in a coronary artery has been suggested. METHODS AND
RESULTS: A total of 191 patients with prior MI were referred to our Hospital between 2010 and June 2013 for a first ablation of VT. Of these, 84 patients (44%) with stable coronary artery disease that underwent a coronary angiography during the index hospitalization were included in this study. A CTO in an infarct-related artery (IRA-CTO) was present in 47 patients (56%). Patients with and without IRA-CTO did not differ in terms of comorbidities, severity of heart failure, presentation of VT or acute outcome of ablation, that was completely successful in 93% of cases. At electroanatomic mapping, IRA-CTO was associated with greater scar and especially with greater area of border zone (34 cm(2) vs. 19 cm(2) , P = 0.001). Median follow-up was 19 months (IQR 18). At follow-up, patients with IRA-CTO had a significantly higher rate of VT recurrence (47% vs. 16%, P = 0.003). At multivariate analysis, IRA-CTO resulted to be an independent predictor of VT recurrence after ablation (HR 4.05, P = 0.004).
CONCLUSIONS: IRA-CTO is an independent predictor of VT recurrence after ablation and identifies a subgroup of patients with high recurrence rate despite a successful procedure. IRA-CTO is associated with greater scars and border zone area; however, this association does not completely justify its proarrhythmic effect.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  catheter ablation; coronary artery occlusion; ischemic cardiomyopathy; myocardial infarction; ventricular tachycardia

Mesh:

Year:  2015        PMID: 25598359     DOI: 10.1111/jce.12622

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  11 in total

1.  "Spiral stenting"-creating a subintimal neo-luminal helix around a massively calcified ostial chronic total occlusion of the right coronary artery in a patient with recurrent ventricular tachycardia.

Authors:  Kambis Mashayekhi; Zivile Valuckiene; Hans Neuser; Marlon Walter; Wolfgang Gappmaier; Thomas Kaiser; Franz-Josef Neumann; Ibrahim Akin; Michael Behnes
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

2.  Ventricular fibrillation storm after revascularization of chronic total occlusion of the left anterior descending artery: is this reperfusion arrhythmia?

Authors:  Xingji Liu; Binay Kumar Adhikari; Tianlong Chen; Yonggang Wang; Quan Liu; Shudong Wang
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

3.  Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10-Year Follow-Up Study.

Authors:  Taek Kyu Park; Seung Hun Lee; Ki Hong Choi; Joo Myung Lee; Jeong Hoon Yang; Young Bin Song; Joo-Yong Hahn; Jin-Ho Choi; Hyeon-Cheol Gwon; Sang Hoon Lee; Seung-Hyuk Choi
Journal:  J Am Heart Assoc       Date:  2021-03-04       Impact factor: 5.501

4.  Catheter ablation of ventricular tachycardia in the setting of electrical storm after revascularization of a chronic total occlusion of the right coronary artery: An uncommon presentation of reperfusion arrhythmia.

Authors:  Sebastian Koenig; Arash Arya; Gerhard Hindricks; Borislav Dinov
Journal:  HeartRhythm Case Rep       Date:  2016-07-22

5.  Comparison among Different Scoring Systems in Predicting Procedural Success and Long-Term Outcomes after Percutaneous Coronary Intervention in Patients with Chronic Total Coronary Artery Occlusions.

Authors:  Artis Kalnins; Ieva Strele; Aivars Lejnieks
Journal:  Medicina (Kaunas)       Date:  2019-08-16       Impact factor: 2.430

6.  Impact of recanalization of chronic total occlusion on left ventricular electrical remodeling.

Authors:  Kennosuke Yamashita; Wataru Igawa; Morio Ono; Takehiko Kido; Toshitaka Okabe; Naoei Isomura; Hiroshi Araki; Masahiko Ochiai
Journal:  Pacing Clin Electrophysiol       Date:  2019-04-25       Impact factor: 1.976

Review 7.  Chronic total occlusion percutaneous coronary intervention in everyday clinical practice - an expert opinion of the Association of Cardiovascular Interventions of the Polish Cardiac Society.

Authors:  Leszek Bryniarski; Maksymilian P Opolski; Jarosław Wójcik; Maciej Lesiak; Tomasz Pawłowski; Jakub Drozd; Wojciech Wojakowski; Sławomir Surowiec; Maciej Dąbrowski; Adam Witkowski; Dariusz Dudek; Marek Grygier; Stanisław Bartuś
Journal:  Postepy Kardiol Interwencyjnej       Date:  2021-03-27       Impact factor: 1.426

8.  Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long-Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator (the eCTOpy-in-ICD Study).

Authors:  Ivo M van Dongen; Dilek Yilmaz; Joëlle Elias; Bimmer E P M Claessen; Ronak Delewi; Reinoud E Knops; Arthur A M Wilde; Lieselot van Erven; Martin J Schalij; José P S Henriques
Journal:  J Am Heart Assoc       Date:  2018-05-02       Impact factor: 5.501

Review 9.  Chronic Total Occlusion Percutaneous Coronary Intervention: Evidence and Controversies.

Authors:  Peter Tajti; Emmanouil S Brilakis
Journal:  J Am Heart Assoc       Date:  2018-01-12       Impact factor: 5.501

10.  Incidence and characteristics of ventricular tachycardia in patients after percutaneous coronary revascularization of chronic total occlusions.

Authors:  Sebastian König; Enno Boudriot; Arash Arya; Julia-Anna Lurz; Marcus Sandri; Sandra Erbs; Holger Thiele; Gerhard Hindricks; Borislav Dinov
Journal:  PLoS One       Date:  2019-11-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.